I. Abstract approval policy
1.1 It is assumed that all SHS abstracts will have at least one SHS PI as a co-author. The PI co-author is responsible for ensuring that the abstract abides by SHS standards and guidelines. If none of the PIs is a co-author, the abstract must be approved by the PI who works most closely with the authors. The title of the abstract should include the phrase "Strong Heart Study" whenever possible.
1.2 If the abstract has an NIH co-author, it must be submitted for NHLBI review. Comments will be returned to the email address provided by the author in the submission process. Please submit the abstract to the following email address for NHLBI Review: firstname.lastname@example.org
1.3 Abstracts must be sent to Dakota Center, Oklahoma Center, and Arizona Center for approval by their IRBs which include area IHS IRBs. Please include a brief LAY SUMMARY of the work to be presented. Please specify that the abstract is being forwarded for Dakota/Oklahoma/Arizona Center IRBs approval, include information about the meeting or other venue intended for the presentation, and send the abstract to:
Wendy Lawrence, R.N.
Strong Heart Study
Missouri Breaks Industries Research, Inc.
118 S. Willow Street
PO Box 1824
Eagle Butte, SD 57625
Phone: (605) 964-1260
Fax: (605) 964-1263
Ying Zhang, MD PhD
Univ. of Oklahoma Health Sciences Center
801 N.E. 13th Street, Room 303
Oklahoma City, OK 73104
Phone: (405) 271-2229 x48073
Fax: (405) 271-4390
Clinical Research Coordinator
MedStar Health Research Institute
1616 E. Indian School Road, Ste 480
Phoenix, AZ 85016
1.4 Prior to presenting the paper, the presenting author should verify (if notice has not been received) that the Dakota Center IRB (Aberdeen Area IRB) and Oklahoma Center IHS IRB approval has been obtained. The information can be found at http://strongheartstudy.org/Research/Papers/TribalApprovalLogs.aspx#386781871-oklahoma-tribal-approval-logs